Accession Number : AD1012119


Title :   Evaluation of RSDL, M291 SDK, 0.5% Bleach, 1% Soapy Water and SERPACWA. Part 12: Challenge with EA1212 (GF, cyclosarin)


Descriptive Note : Technical Report,18 Jul 2006,14 Sep 2010


Corporate Author : U.S. Army Medical Research Institute of Chemical Defense Aberdeen Proving Ground United States


Personal Author(s) : Braue,Ernest Jr H ; Doxzon,Bryce F ; Lumpkin,Horace L ; Smith,Kelly H ; Devorak,Jennifer L ; Stevenson,Robert S


Full Text : https://apps.dtic.mil/dtic/tr/fulltext/u2/1012119.pdf


Report Date : 01 Jan 2016


Pagination or Media Count : 77


Abstract : An important objective of the Project Solicitation for Agent Therapeutics (Task Area 2.H) was to determine the effectiveness of current medical countermeasures against the acute toxicity of nerve agents. This project evaluated the efficacy of skin decontamination products and barrier skin creams. Doctrine described the use of Skin Exposure Reduction Paste Against Chemical Warfare Agents (SERPACWA)as a barrier skin cream and the M291 Skin Decontamination Kit (SDK), 0.5% hypochlorite solution (household bleach diluted 1 to 10)and1% soapy water solution (liquid dish detergent) to decontaminate intact skin exposed to chemical warfare agents. Reactive Skin Decontamination Lotion (RSDL) was approved by the FDA in 2003 and subsequently selected as the Joint Services Personnel Skin Decontamination System (JSPDS) to replace the M291 SDK. This report, the twelfth in a series, directly compares the efficacy of the barrier skin cream SERPACWA and the four listed decontamination products in the haired guinea pig model following exposure to GF(EA1212).


Descriptors :   Decontamination , Bleaching agents , Skin(Anatomy) , therapeutics , Countermeasures , chemical warfare agents


Distribution Statement : APPROVED FOR PUBLIC RELEASE